SCHEMBL6176595

SCHEMBL6176595

[C]1CC=C2C=CC=C12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2572500 0.91
SCHEMBL2962435 0.60
SCHEMBL8973287 0.60
SCHEMBL27974613 0.58
SCHEMBL26292 0.57
SCHEMBL2047040 0.55
SCHEMBL2051532 0.55
SCHEMBL8466052 0.54
SCHEMBL28952826 0.54
SCHEMBL8467152 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5959132-A Mononuclear and polynuclear transition metal complexes with pentalene ligands bound to single metal atoms STUDIENGESELLSCHAFT KOHLE MBH (DE) 1999-09-28 US claimed
EP-0897926-A1 Mononuclear and polynuclear transition metal complexes with pentalene ligands bound to single metal atoms Studiengesellschaft Kohle mbH (DE) 1999-02-24 EP claimed
EP-3679038-A1 SUBSTITUTED IMIDAZOQUINOLINES Biontech SE (DE) 2020-07-15 EP disclosed
EP-3679025-A1 SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7 Biontech SE (DE) 2020-07-15 EP disclosed
WO-2019048350-A1 SUBSTITUTED IMIDAZOQUINOLINES BIONTECH AG (DE) 2019-03-14 WO disclosed
WO-2019048353-A1 SUBSTITUTED IMIDAZOQUINOLINES AS AGONISTS OF TLR7 BIONTECH AG (DE) 2019-03-14 WO disclosed
US-9932423-B2 Hydrogenation of annulated cyclopentadienyl metal complexes and metallocene catalysts comprising such EXXONMOBIL CHEMICAL PATENTS INC. (US) 2018-04-03 US disclosed
US-20170088643-A1 HYDROGENATION OF ANNULATED CYCLOPENTADIENYL METAL COMPLEXES AND METALLOCENE CATALYSTS COMPRISING SUCH UNIVATION TECHNOLOGIES, LLC 2017-03-30 US disclosed
WO-2017013210-A1 TREATMENT AND PREVENTION OF VIRAL DISEASES WITH 2,3-DIHYDROBENZOFURAN-5-YL COMPOUNDS 4SC AG (DE) 2017-01-26 WO disclosed
EP-2867237-A1 BIFLUORODIOXALANE-AMINO-BENZIMIDAZOLE KINASE INHIBITORS FOR THE TREATMENT OF CANCER, AUTOIMMUNEINFLAMMATION AND CNS DISORDERS 4SC Discovery GmbH (DE) 2015-05-06 EP disclosed
WO-2014001464-A1 BIFLUORODIOXALANE-AMINO-BENZIMIDAZOLE KINASE INHIBITORS FOR THE TREATMENT OF CANCER, AUTOIMMUNEINFLAMMATION AND CNS DISORDERS 4SC DISCOVERY GMBH (DE) 2014-01-03 WO disclosed
US-20030119835-A1 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents PFIZER PRODUCTS, INC. 2003-06-26 US disclosed
US-6531492-B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents PFIZER INC. 2003-03-11 US disclosed
EP-1273576-A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents Pfizer Products Inc. (US) 2003-01-08 EP disclosed
EP-1273580-A1 Sulfonyl heteroaryl triazoles as anti-inflammatory and analgesic agents Pfizer Products Inc. (US) 2003-01-08 EP disclosed
EP-1273582-A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents Pfizer Products Inc. (US) 2003-01-08 EP disclosed
EP-1233959-A1 HETEROCYCLO-ALKYLSULFONYL PYRAZOLE DERIVATIVES AS ANTI-INFLAMMATORY/ANALGESIC AGENTS Pfizer Products Inc. (US) 2002-08-28 EP disclosed
WO-2001040216-A1 HETEROCYCLO-ALKYLSULFONYL PYRAZOLE DERIVATIVES AS ANTI-INFLAMMATORY/ANALGESIC AGENTS PFIZER PRODUCTS INC. (US) 2001-06-07 WO disclosed
US-5959132-A Mononuclear and polynuclear transition metal complexes with pentalene ligands bound to single metal atoms STUDIENGESELLSCHAFT KOHLE MBH (DE) 1999-09-28 US disclosed
EP-0897926-A1 Mononuclear and polynuclear transition metal complexes with pentalene ligands bound to single metal atoms Studiengesellschaft Kohle mbH (DE) 1999-02-24 EP disclosed